共 50 条
- [4] Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor FRONTIERS IN ONCOLOGY, 2022, 12
- [10] Response to a combination of erlotinib and bevacizumab therapy after immune checkpoint inhibitor CLINICAL RESPIRATORY JOURNAL, 2020, 14 (05): : 500 - 501